In the past decade, KPD has become the fastest growing source of transplantable live donor kidneys, overcoming the barrier faced by LD deemed incompatible Histone Acetyltransferase inhibitor with their intended recipients.[8] Reasons for participating in KPD include primarily blood group incompatibility and sensitization of the recipient against the donor, but may additionally include the potential for improvement in transplant quality and tissue compatibility. In the absence of a well-organized DDKTx program, or when transplantation
with HLA-desensitization protocols and ABO incompatible transplantation is either unaffordable or poses a greater risk due to more intensive immunosuppression, KPD promises hope to a growing number of ESKD patients.[9-11] Of all the advances made in KTx in the last 25 years, KPD has the greatest potential to expand the LD pool. However, KPD is still in its infancy and needs further development. Ethical, administrative, and logistical barriers initially proved formidable and prevent the implementation of KPD programs. Lack of awareness, counselling and participation are other important issues. Although KPD was underutilized in India, recently, KPD transplantation has been performed Natural Product Library screening more frequently.[9-19] KPD is feasible for any centre that performs LDKTx. However, we do not have a National KPD program and one of the limitations of a single centre
KPD program is that the donor pool is small. A national KPD program will substantially increase the donor pool, but there are some barriers that need to be overcome to enable establishing a successful national program (Table 2). Nevertheless,
recent studies are valuable for encouraging the participation of KPD pairs and transplant centres in the national KPD program. Issues regarding legal permission in our country Concerns regarding the donor-recipient age difference affecting the allograft outcome. Is there any difference in graft survival between KPD versus living donor kidney transplantation (LDKTx)? Whether increased cold ischemia find more time (CIT) would affect the allograft outcomes? Waiting time for deceased donor versus KPD transplantation/LDKTx. Should KPD be performed for better human leukocyte antigen (HLA) matching? In developing countries such as India, extending KPD to HLA-mismatched, albeit compatible patient-donor pairs would increase well-matched LDKTx, resulting in use of less immunosuppression and fewer expenses, lower infective morbidity, and better survival. A model for KPD based on HLA matching is presented. They have shown that 40% of prospective recipients without well-matched donors would find a donor-swap pair based on HLA matching within a year, with coordination among four national centres and a shared HLA registry.[15] We have performed a total of 160 KPD KTx at our single centre from 2000 to 2014.